Long-Term Tolvaptan Treatment in Refractory Heart Failure

Background: The vasopressin type-2 receptor antagonist tolvaptan is an essential tool in the management of decompensated heart failure (HF) in the inpatient setting for short-term use with careful monitoring. There is conflicting evidence, however, for its long-term use. Methods and Results: In this...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Circ Rep
Glavni autori: Imamura, Teruhiko, Kinugawa, Shintaro, Muramatsu, Toshihiro, Shiga, Tsuyoshi, Ogimoto, Akiyoshi, Anzai, Toshihisa, Hagiwara, Nobuhisa, Tsutsui, Hiroyuki, Komuro, Issei, Kinugawa, Koichiro
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Circulation Society 2019
Teme:
Original article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7897549/
https://ncbi.nlm.nih.gov/pubmed/33693080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0064
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items